Navigation Links
Amicus Therapeutics Announces Third Quarter 2008 Financial Results
Date:11/3/2008

08 representing two different revenue streams from the Shire agreement. Upon signing the agreement, Amicus received an upfront payment of $50 million that will be recognized as revenue on a straight-line basis over 18 years from the date of the agreement. In the third quarter 2008, Amicus recognized $0.7 million of the Shire upfront payment and $3.0 million of research revenue on reimbursed research and development costs.

Amicus today reiterated its most recent guidance for 2008 cash burn of $40 million to $50 million. The Company also reiterated that it does not expect to raise cash from any equity financings in 2008.

The differences between U.S. GAAP and non U.S. GAAP financial results are itemized in Tables 2 and 3, and are primarily due to pre-tax stock compensation expense

Use of Non-GAAP Financial Measures

Amicus' "non-GAAP net loss" and "non-GAAP diluted net loss per common share" financial measures are defined as reported, or GAAP, net loss and diluted net loss per common share excluding certain items further discussed below. Amicus' management uses these non-GAAP financial measures to establish financial goals and to gain an understanding of the comparative financial performance of Amicus from year to year and quarter to quarter. Accordingly, Amicus believes investors' understanding of Amicus' financial performance is enhanced as a result of disclosing these non-GAAP financial measures. Non-GAAP net loss and diluted net loss per common share should not be viewed in isolation or as a substitute for reported, or GAAP net loss and diluted net loss per common share.

(1) Stock option expense -- Non-GAAP net loss and diluted net loss per

common share exclude the impact of the stock option expense recorded

in accordance with SFAS No. 123R. Amicus believes that excluding the

impact of expensing stock options better reflects the recurring

economic characteristics of its business.

<
'/>"/>
SOURCE Amicus Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Amicus Therapeutics Announces Third Quarter 2008 Results Release Date
2. Amicus Therapeutics to Present at the 2008 UBS Global Life Sciences Conference
3. Amicus Therapeutics Opens Research Facility in San Diego
4. Amicus Therapeutics to Present at the 2008 BioCentury NewsMakers in the Biotech Industry Conference
5. Amicus Therapeutics Announces Second Quarter 2008 Results Release Date
6. Amicus Therapeutics Announces First Quarter 2008 Financial Results
7. Amicus Therapeutics to Present at the Morgan Stanley Global Healthcare Unplugged Conference
8. Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera(TM) for Gaucher Disease
9. Amicus Therapeutics to Present at the BIO CEO & Investor Conference 2008
10. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
11. Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... FAIRFIELD, Connecticut (PRWEB) October 31, 2014 ... remains sanitary is an uphill battle in many corners ... for a rural farming community in northwestern Bolivia where ... is where a group from Fairfield University’s School of ... at the Unidad Academica Campesina (UAC), “the united college ...
(Date:10/31/2014)... October 30, 2014 Two separate ... were hosted by Charm Sciences at its Andover, ... week in the US, the participants discussed international ... hygiene management, and process verification, and received hands-on ... This was the first visit to the United ...
(Date:10/31/2014)... (PRWEB) October 31, 2014 This ... Global and China Biocides industry. The report provides ... and industry chain structure as well as industry ... including China’s domestic market as well as Global ... analysis. The report on the Chinese biocides ...
(Date:10/31/2014)... 2014 ENVIRON , an ... today that Dr. Harvey Clewell III has rejoined ... work closely with senior professionals in ENVIRON’s Health ... serve at The Hamner Institutes for Health Sciences ... where he is Director, Center for Human Health ...
Breaking Biology Technology:Fairfield University School of Engineering project reduces illness in rural community 2Fairfield University School of Engineering project reduces illness in rural community 3Charm Sciences Hosts Executives from Latin America for Dairy Safety Executive Seminar 2Biocides Market for International & Chinese Regional Development Analysis Now Available at DeepResearchReports.com 2Biocides Market for International & Chinese Regional Development Analysis Now Available at DeepResearchReports.com 3Internationally recognized health scientist Dr. Harvey Clewell renews association with ENVIRON 2Internationally recognized health scientist Dr. Harvey Clewell renews association with ENVIRON 3
... a world-wide leader in custom genomic and molecular ... position itself as the Next-Generation Sequencing Provider of ... attributed to the company,s ability to respond quickly ... genomics technologies. Building on this success, SeqWright announced ...
... that a new market research report is available in ... 1011 http://www.reportlinker.com/p0358381/Industrial-Biotechnology-China-News-1011.html ... not past." Owing to the monetary easing policy adopted ... affect almost all industries in China, including corn products. ...
... can be used to control the electrical properties ... devices and highly sensitive sensors. This year,s ... into graphene, recognising its potential for many applications ... technology. The UK,s National Physical Laboratory, along with ...
Cached Biology Technology:SeqWright Continues Expansion of Next-Generation Sequencing Capabilities 2Reportlinker Adds Industrial Biotechnology China News 1011 2New research shows how light can control electrical properties of graphene 2
(Date:10/31/2014)... Geologists are letting the air out of a nagging mystery ... have long speculated as to why animal species didn,t flourish ... to prosper at the end of the Proterozoic period, about ... stretch before that, when most researchers think there also was ... so great then, after all. , In a study published ...
(Date:10/31/2014)... uncovered key steps involved in programmed cell death, offering ... cancers and neurodegenerative diseases. , The research teams ... to discover the three-dimensional structure of a key cell ... in how it causes cell death. Their studies were ... Proceedings of the National Academy of Sciences ...
(Date:10/30/2014)... soil subsidence and reduce greenhouse gas emissions, according ... by Dartmouth College researchers and their colleagues. , ... to continually measure the fluctuations of both carbon ... in the journal by Global Change ... organic soils has resulted in vast soil subsidence ...
Breaking Biology News(10 mins):Lack of oxygen delayed the rise of animals on Earth 2A matter of life and death: Cell death proteins key to fighting disease 2Dartmouth study finds restoring wetlands can lessen soil sinkage, greenhouse gas emissions 2
... A deadly, rare type of soft-tissue cancer may be completely ... growth, UT Southwestern Medical Center researchers report. In the ... found that inhibiting the action of a protein called BRD4 ... malignant peripheral nerve sheath tumors (MPNSTs). "This study identifies ...
... international group of investigators has discovered new genes, pathways ... to rheumatoid arthritis (RA). The findings are published online ... association study (GWAS) meta-analysis in more than 100,000 people ... sites of genetic variation involved in risk for RA. ...
... of Excellence for Coral Reef Studies has been awarded $A28m ... Centre will be reorganised into three new research programs - ... Responding to a Changing World. , Centre Director, Professor Terry ... provide understanding of coral reefs and their interaction with ...
Cached Biology News:UTSW study identifies potential therapeutic target for incurable, rare type of soft-tissue cancer 2Researchers complete a milestone in defining the genetic basis of rheumatoid arthritis 2
... A full-featured high-performance ICP-MS system designed for ... interface, Omega II off-axis ion lens, true ... 7500a can handle the widest range of ... the 7500a now includes as standard Agilents ...
... Identical to the DH-2000, except that it ... 190-1700 nm wavelength range and comes with a ... up to 5 Hz) The DH-2000 ... spectrum of deuterium and tungsten halogen light sources ...
One controller two vessel system suitable for early stage of fermentation, and small scale, Application : cultivation of microorganisms and human or animal cells...
... handy dispensers save space and organize ... other garb. They are the perfect ... used in labs, processing and manufacturing. ... and the particles they attract. Many ...
Biology Products: